Hotelbuchung
Hotel Registration
Grußwort
Welcome address
Beteiligte Gesellschaften
Societies involved
DOG Information
DOG Information
Eröffnung des Kongresses
Opening Ceremony
Preise
Awards
Ablauf der Tagung 2003
General overview of congress
Lageplan der Räumlichkeiten
Map of Congress Center
Wissenschaftliche Themen
Scientific topics
Symposien
Symposia
Wissenschaftliches Programm
Scientific program
Posterpräsentationen
Poster Presentation
Kurse
Courses
Begleitende Veranstaltungen
Accompanying program
Arbeitssitzungen
Working sessions
Rahmenprogramm
Social program
Allgemeine Informationen
General Information
Autorenindex
Index of Authors
Industrieaussteller
Commercial exhibitors
Sponsoren
Sponsors
Impressum
DOG Homepage
Abstract
Abstract
CEACAM1 in Endothelial Cell Differentiation and Angiogenesis an In-vivo Model for Retinopathy
Horst A. K.1, Zubaty V.2, Valtink M.3, Wörpel V.2, Beauchemin N.4, Engelmann K.3, Wagener C.1
1Institut für Klinische Chemie, Zentrum für Theoretische Medizin I und 2Augenklinik, Universitätsklinikum Hamburg-Eppendorf, Hamburg; 3Augenklinik, Universitätsklinikum Dresden, Dresden; 4McGill Cancer Centre, McGill University, Montreal, QC, Kanada
CEACAM1 (CEA-related cell adhesion molecule 1) is a ubiquitously expressed cellular adhesion molecule (epithelia, endothelia and leukocytes) of the CEA-family of immunoglobulins, that participates in early angiogenic events. Furthermore, CEACAM1 expression is dysregulated in a variety of human tumours. The angiogenic properties of CEACAM1 seem to be based in part on the signal transduction potential through its cytoplasmic domain. Founded on this information, transgenic mice (Tie2-CEACAM1-transgenic mice) were generated that overexpress CEACAM1 under the endothelial cell-specific control of the Tie2 receptor tyrosine kinase. The receptor tyrosine kinases Tie1 and Tie2 and their ligands, the angiopoietins, are central players in the regulation of angiogenesis. Overexpression of CEACAM1 in the endothelia of transgenic mice was verified by flow cytometric analysis. So far, no major defects in the vasculature of Tie2-CEACAM1-transgenic mice could be detected.
Based on these results, we anticipa